EDGE Surgical Launches Universal Depth Gauge - A Breakthrough in Orthopedics

January 7, 2026 10:09 AM

EDGE Surgical, Inc, the innovative brand behind the world's only electronic depth gauge for orthopedic surgery, today announced the launch of a Universal Depth Gauge compatible with all major orthopedic plating systems. With patent-pending dynamic calibration technology, the Ortho EDG® is the world's first depth gauge to work with every major plating system - a quantum leap forward in depth gauge technology.The Universal Depth Gauge furthers the...

Read more

AMEEREX Enters Strategic Partnership With Patagonia Lithium (ASX: PL3), Gaining Exposure to Inferred and Indicated 551,000 tonnes of Lithium Carbonate Equivalent JORC-Validated Lithium Resource by WSP Australia

January 7, 2026 10:05 AM

AMEEREX Corporation ("Ameerex" or the "Company") today announced that it has entered into a strategic partnership with Patagonia Lithium Limited (ASX:PL3), working towards securing a material economic interest in a world-class lithium brine resource located in Argentina's Lithium Triangle, one of the most important lithium-producing regions globally.The announcement follows Patagonia Lithium's disclosure of a Significant Maiden Inferred resource...

Read more

Medical Care Technologies' Infinite Auctions to Offer Original Art by Iconic Artist Rob Prior Signed by Stan Lee, Chris Evans, Al Pacino & More

January 7, 2026 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) is excited to announce that its subsidiary, Infinite Auctions, will host "The Legends Art Auction," an exclusive event showcasing a remarkable collection of original art pieces by renowned artist Rob Prior and others. This highly anticipated auction will feature:Captain America artwork signed by actor Chris EvansThree original paintings of Stan Lee and Marvel charactersOriginal painting of Peyton...

Read more

Phase 1 Equity Announces it's First Practice Addition of The Year, Bringing on a Multi-Site Orthodontic Practice Located in Ohio

January 7, 2026 9:00 AM

Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome another leading multi-site orthodontic practice based in Ohio to its growing network.This practice treats each patient as a family member and delivers flexibility in offering highly personalized care backed by state-of-the-art technology. This community-based practice thrives on delivering exceptional care...

Read more

Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development

January 7, 2026 9:00 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, today announced the start of GMP manufacturing of GEMINI and placebo. This manufacturing run will provide the Company with clinical drug supply for later stage clinical studies."We are delighted to be working with a leading global contract manufacturing organization," said James Rolke,...

Read more

Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA)

January 7, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced the successful outcome of a Type B pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA). The meeting provided a clear regulatory roadmap for the Company's investigational new drug, acetylsalicylic acid 162 mg sublingual...

Read more

Ovation Science Secures New Canadian Patent; Strengthening IP Position and Expanding Commercial Opportunities for Topical Cannabis Products

January 7, 2026 8:00 AM

Ovation Science Inc. (CSE:OVAT)(OTC PINK:OVATF) ("Ovation" or the "Company"), a research and development company focused on the commercialization, patenting, and licensing of advanced cannabinoid-based topical / transdermal products, today announced the issuance of a new Canadian patent covering proprietary topical formulations containing CBD and THC.The patent, entitled "Composition and method for transdermal delivery of cannabidiol (CBD) and...

Read more

Wellgistics Health Provides 2026 Corporate Outlook

January 7, 2026 7:40 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (‘AI') platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today provided a corporate outlook for 2026 to stakeholders."Three months following my return to the role of President at Wellgistics, the Company now has a clear...

Read more

Protagonist Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference 2026

January 7, 2026 7:30 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference taking place January 12-15, 2026 in San Francisco, CA. The Company will also participate in one-on-one meetings.44th Annual J.P. Morgan Healthcare Conference - January 12-15, 2026Format: Company PresentationDay/Time:...

Read more

Neurodivergent Empowerment Institute Presents: New Moon Drum Circle and Sound Bath

January 7, 2026 7:00 AM

The Neurodivergent Empowerment Institute, part of the Bionic Bloom Wellness Collective family of wellness centers, invites the community to a transformative New Moon Drum Circle and Sound Bath on Sunday, January 18, 2026 from 6:00 PM to 8:00 PM EST at NEI's St. Petersburg campus. (Humanitix)This guided New Moon experience offers a supportive space for participants to release what no longer serves them, set intentions for the coming lunar cycle,...

Read more

AMC Health Announces Breakthrough in AI-Driven Alert Precision for Virtual Care Program

January 7, 2026 6:00 AM

AMC Health, a leading provider of virtual care and chronic condition management, today announced a major advancement in its AI-driven clinical alerting framework. This AI-driven framework uses longitudinal, patient-specific baselines and time-series pattern detection to significantly improve the precision of physiometric alerts while reducing unnecessary clinician workload, without compromising patient safety or outcomes. Leveraging more than...

Read more

Patient Outcomes First: How James Richman's OTLEN Brings AI to Clinics

January 7, 2026 6:00 AM

For most patients, the frustrations of the healthcare system are measured in minutes spent in waiting rooms or months waiting for insurance approvals. But for James Richman, a financier turned technology CEO, the problem is measured in something else entirely: the invisible "handoffs" where vital data - and billions of dollars - simply disappear. Richman is the CEO of OTLEN, a company that has quietly positioned itself as the "central nervous...

Read more

Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference

January 7, 2026 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14th, 2026, at 2:15 pm PT. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation.About Amphastar Pharmaceuticals, Inc.:Amphastar is a...

Read more

Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension

January 7, 2026 2:25 AM

Pentixapharm Holding AG (Frankfurt Prime Standard:PTP), an advanced clinical-stage biotech developing novel radiopharmaceuticals, today announced that it has received the formal written minutes from its recent scientific advice meeting with the U.S. Food and Drug Administration (FDA) for the planned Phase 3 PANDA study of [⁶⁸Ga]Ga-PentixaFor, the company's leading CXCR4-directed flagship program. The PANDA study will evaluate the radiodiagnostic...

Read more

CellRight Tech: Private Equity Funding Secured

January 7, 2026 2:00 AM

CellRight Technologies, LLC, a specialist in regenerative allografts for patient implants, announces that it has secured private equity funding from Harwood Capital through its parent company, Tissue Regenix Group plc (TRG) to support commercial growth plans for the business. The management team, led by newly appointed CEO and Chairman, Jay LeCoque, remain focused on restoring TRG revenue growth and profitability, and driving sustainable,...

Read more

WELT Unveils the World's First "AI-Combo Drug" at CES 2026

January 7, 2026 12:00 AM

WELT, the Samsung spin-off digital‑pharmaceutical company behind the KFDA‑approved and CE‑certified insomnia Digital Therapeutics ‘SleepQ', announced today that it has been named a CES 2026 Innovation Awards Honoree for its groundbreaking AI agent, ‘AgentZ'. AgentZ transforms everyday generic sleep medications into personalized, AI‑enhanced precision therapies-without altering the chemical formulation of the pill. By scanning a QR code placed...

Read more

Theralogix Announces Leadership Transition as Company Concludes a Record Year of Growth

January 7, 2026 12:00 AM

Theralogix, a leading developer of evidence-based nutritional supplements recommended by physicians for more than two decades, announced a strategic leadership transition following a record-breaking 2025. With its sixth consecutive quarter of record-setting performance, achieving 25% growth in both revenue and profit, Theralogix reported its strongest financials in its 23-year history.After more than two decades guiding the company's evolution,...

Read more

ALST Signs Non-Disclosure Agreement with Major Toronto University for Proposed Allstar Sports Centre Development

January 6, 2026 1:35 PM

ALST is pleased to announce the signing of a Non-Disclosure Agreement (NDA) with a large, internationally recognized university located in Toronto, Ontario, to explore the potential development of an Allstar Sports Centre on approximately 8 acres of land.The NDA establishes a confidential framework under which both parties will evaluate the feasibility, scope, and alignment of a multi-use sports and recreation facility designed to support...

Read more

Medical Care Technologies Inc. (OTC Pink:MDCE) Announces Attendance at CES 2026 in Las Vegas

January 6, 2026 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to announce that the CEO and members of the Company's tech team are currently attending the Consumer Electronics Show (CES) 2026 in Las Vegas, Nevada. CES remains the world's largest stage for breakthrough technologies and global innovators, and attendance reflects the Company's continued commitment to remaining at the forefront of emerging AI and digital health innovation. "Being...

Read more

TeleTracking Appoints Derek Ritchea as Chief Strategy Officer

January 6, 2026 9:03 AM

TeleTracking Technologies, a leading provider of healthcare operations solutions, today announced that Derek Ritchea has joined the company as Chief Strategy Officer. In this role, Ritchea will lead a range of key initiatives including monitoring market dynamics to inform strategy, and identifying, evaluating, and executing new high-impact partnerships while strengthening TeleTracking's existing partnerships across the healthcare landscape."I am...

Read more